sunitinib malate — Medica

Initial criteria

• age ≥ 18 years
• Patient has tried at least one systemic chemotherapy regimen (e.g., carboplatin, paclitaxel, cisplatin, doxorubicin, cyclophosphamide, or etoposide)

Approval duration

1 year